EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings

Clinical trial NCT07056036 · COMPLETED

Trial details

NCT number: NCT07056036
Sponsor: BTL Industries Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Self-Control Food Cravings

Start date: 2024-11-01
Primary completion: 2025-10-10
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.